Hemagen Diagnostics, Inc.
OTC: HMGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William Hales
- Employees
- 15
- Headquarters
- Columbia, United States
- IPO year
- 1993
- Market cap
- $4.7K
- Website
- https://www.hemagen.com
Loading HMGN…
Loading profile data…Frequently asked questions about HMGN
What does Hemagen Diagnostics, Inc. (HMGN) do?
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase protei...
Where does HMGN trade?
Hemagen Diagnostics, Inc. (HMGN) trades on the Other OTC.
What sector is HMGN in?
Hemagen Diagnostics, Inc. (HMGN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hemagen Diagnostics, Inc.?
William Hales is the chief executive officer of Hemagen Diagnostics, Inc. (HMGN).
Where is Hemagen Diagnostics, Inc. headquartered?
Hemagen Diagnostics, Inc. is headquartered in United States.
Does HMGN pay a dividend?
Hemagen Diagnostics, Inc. (HMGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HMGN go public?
Hemagen Diagnostics, Inc. (HMGN) completed its initial public offering in 1993.